Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCentrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Benzylpenicillin (procaine) monohydrate, Sterile with l...

CEP 2024-202 - Rev 00
Valid
Chemical
2025-07-01
115
Centrient Pharmaceuticals

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCentrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Certificate Number : CEP 2024-202 - Rev 00

Status : Valid

Issue Date : 2025-07-01

Type : Chemical

Substance Number : 115

Centrient Pharmaceuticals

Looking for Certificates of Suitability (CEPs) for CEP 2024-202 - Rev 00 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl

Looking for Certificates of Suitability (CEPs) for CEP 2024-202 - Rev 00 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl 1

20

Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

One of their significant offerings is Benzylpenicillin (procaine) monohydrate, Sterile with lecithin and polysorbate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2024-202 - Rev 00

This Chemical Type CEP, issued on July 01, 2025, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 115 associated with this CEP further emphasizes